Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19055432 | ANATOMICAL MANIPULATION DEVICE | February 2025 | January 2026 | Allow | 11 | 2 | 0 | Yes | No |
| 18822854 | APPARATUS AND METHOD FOR MANIPULATING THE NERVOUS SYSTEM BY ELECTRIC FIELDS | September 2024 | October 2025 | Allow | 13 | 2 | 1 | No | No |
| 18615896 | INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE AND MANUFACTURE | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18615517 | SYSTEM AND METHOD FOR TRANSMITTING RADIO FREQUENCY ENERGY AT A VIRUS RESONANT FREQUENCY TO DISABLE IT | March 2024 | April 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18688595 | Electrostatic Therapeutic Device | March 2024 | June 2025 | Allow | 16 | 0 | 0 | No | No |
| 18441814 | ELECTRODE ASSEMBLY | February 2024 | September 2025 | Allow | 19 | 1 | 1 | No | No |
| 18435322 | TREATMENT DEVICE | February 2024 | December 2024 | Allow | 10 | 1 | 0 | No | No |
| 18422099 | FLUID SEALS FOR CATHETER PUMP MOTOR ASSEMBLY | January 2024 | February 2025 | Allow | 13 | 1 | 0 | No | No |
| 18410217 | IMPLANTABLE POWER ADAPTER | January 2024 | July 2025 | Allow | 18 | 1 | 0 | No | No |
| 18393268 | STIMULATION WITH ELECTRODE ARRAYS | December 2023 | January 2025 | Allow | 13 | 1 | 0 | No | No |
| 18540437 | MINIMALLY INVASIVE LEADLESS NEUROSTIMULATION DEVICE | December 2023 | January 2025 | Allow | 13 | 1 | 0 | No | No |
| 18528358 | METHOD OF USING PHOTON MODULATION FOR REGULATION OF HORMONES IN MAMMALS | December 2023 | February 2025 | Allow | 15 | 1 | 0 | No | No |
| 18514470 | PARTIAL NERVE CONDUCTION BLOCK USING A SEPARATED INTERFACE NERVE ELECTRODE (SINE) | November 2023 | September 2025 | Allow | 22 | 1 | 1 | No | No |
| 18388191 | METHODS AND SYSTEMS OF IMPROVING AND MONITORING ADDICTION USING CUE REACTIVITY | November 2023 | January 2026 | Allow | 26 | 5 | 0 | No | No |
| 18559377 | NEURAL IMPLANT BASED ON A CELLULOSE THIN FILM AND CORRESPONDING FABRICATION PROCESS | November 2023 | October 2025 | Allow | 23 | 0 | 0 | No | No |
| 18379221 | BLOOD PUMP | October 2023 | December 2024 | Allow | 15 | 1 | 0 | No | No |
| 18485667 | DEVICE FOR ENHANCING MANDIBULAR BONE GROWTH | October 2023 | December 2023 | Allow | 2 | 0 | 0 | Yes | No |
| 18551765 | SYSTEMS AND METHODS FOR IMPLANTABLE ELECTRODES WITH FEEDBACK FOR APPLICATION OF ELECTRIC FIELD THERAPY WITHIN THE BODY | September 2023 | December 2024 | Allow | 15 | 2 | 0 | Yes | No |
| 18229466 | INTERNAL ULTRAVIOLET THERAPY | August 2023 | April 2025 | Allow | 20 | 2 | 0 | Yes | No |
| 18228748 | ELECTRODE CONNECTION AND METHOD THEREFOR | August 2023 | August 2024 | Allow | 12 | 1 | 0 | No | No |
| 18355382 | ELECTRODE SYSTEM FOR ELECTRICAL STIMULATION | July 2023 | June 2025 | Allow | 22 | 1 | 1 | Yes | No |
| 18347073 | BIOELECTRIC OPG TREATMENT OF CANCER | July 2023 | March 2026 | Abandon | 32 | 1 | 0 | No | No |
| 18216925 | Cardiac Pump With Speed Adapted for Ventricle Unloading | June 2023 | March 2025 | Allow | 20 | 2 | 0 | No | No |
| 18215603 | ELECTRICAL STIMULATION DEVICES FOR CANCER TREATMENT | June 2023 | January 2025 | Allow | 19 | 1 | 1 | No | No |
| 18038708 | ELECTRIC FIELD CANCER TREATMENT APPARATUS AND METHOD USING ROTATING ALTERNATING CURRENT ELECTRIC FIELD | May 2023 | January 2024 | Allow | 8 | 1 | 0 | No | No |
| 18037124 | BIOSIGNAL ANALYSIS SYSTEM | May 2023 | September 2025 | Allow | 28 | 0 | 0 | No | No |
| 18195690 | SENSING REFERENCE ELECTRODE FOR PERCUTANEOUS NEUROMODULATION TRIALS | May 2023 | September 2024 | Allow | 17 | 1 | 0 | No | No |
| 18144351 | BIOCOMPATIBLE SOFT PRESSURE SENSOR AND METHOD OF MONITORING PRESSURE SUBCUTANEOUSLY | May 2023 | September 2025 | Allow | 28 | 0 | 0 | No | No |
| 18137614 | SYSTEM AND METHOD FOR IMPLANTABLE NEURAL SENSING AND STIMULATING PROBES | April 2023 | March 2026 | Allow | 34 | 1 | 1 | Yes | No |
| 18137769 | AV SYNCHRONOUS SEPTAL PACING | April 2023 | March 2025 | Allow | 23 | 1 | 1 | Yes | No |
| 18194896 | ELECTRICALLY ANESTHETIZING A PERIPHERAL NERVE WITH ON-DEMAND ELECTRICAL NERVE BLOCK FOR CHRONIC PAIN MANAGEMENT | April 2023 | November 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 18023828 | SYSTEMS AND DEVICES FOR TREATING LUNG TUMORS | February 2023 | October 2025 | Allow | 32 | 0 | 0 | No | No |
| 18175424 | ENDOVASCULAR LEAD DESIGN AND DELIVERY SYSTEMS | February 2023 | February 2026 | Allow | 35 | 1 | 1 | No | No |
| 18171613 | Stimulation Configuration Variation to Control Evoked Temporal Patterns | February 2023 | March 2025 | Allow | 25 | 2 | 0 | No | No |
| 18021257 | Method for Focused Transcranial Electrical Current Stimulation | February 2023 | August 2025 | Allow | 30 | 1 | 0 | No | No |
| 18041657 | ELECTROPORATION SHIELD FOR IMPLANTABLE ELECTRODES | February 2023 | February 2026 | Allow | 36 | 1 | 0 | No | No |
| 18105069 | High Voltage, High Efficiency Sine Wave Generator that Prevents Spikes During Amplitude Adjustments and Switching of Channels | February 2023 | July 2024 | Allow | 17 | 1 | 0 | No | No |
| 18104570 | METHOD FOR NEUROMODULATION TREATMENT OF LOW URINARY TRACT DYSFUNCTION | February 2023 | September 2023 | Allow | 8 | 1 | 0 | No | No |
| 18103652 | TREATMENT OF CONGESTIVE HEART FAILURE WITH ELECTRICAL STIMULATION, AND ASSOCIATED SYSTEMS AND METHODS | January 2023 | September 2024 | Abandon | 19 | 1 | 0 | No | No |
| 18069606 | ENERGY CONSUMPTION REDUCTION FOR MEDICAL DEVICE CONNECTIVITY | December 2022 | June 2025 | Allow | 30 | 0 | 0 | No | No |
| 18079361 | DEVICES, SYSTEMS, AND METHODS FOR DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER | December 2022 | February 2026 | Allow | 38 | 1 | 0 | No | No |
| 17928736 | RADIO FREQUENCY MICRONEEDLE ARRAY CONTROL DEVICE, METHOD AND RADIO FREQUENCY MICRONEEDLE THERAPEUTIC APPARATUS | November 2022 | October 2025 | Allow | 34 | 1 | 0 | No | No |
| 17924363 | INTEGRATED ARTIFICIAL PANCREAS WITH MULTIPLE INFUSION MODES | November 2022 | July 2025 | Allow | 32 | 1 | 0 | No | No |
| 17923606 | DIABETIC COMPLICATION MONITORING DEVICE AND DIABETIC COMPLICATION MANAGEMENT SYSTEM USING SAME | November 2022 | July 2025 | Allow | 32 | 1 | 0 | No | No |
| 17959540 | PHYSIOLOGICAL PARAMETER SENSOR HELMET | October 2022 | June 2024 | Allow | 21 | 3 | 0 | Yes | No |
| 17916564 | METHOD AND APPARATUS FOR CORRECTING ELECTROCARDIOGRAM READING | September 2022 | October 2025 | Allow | 37 | 1 | 0 | No | No |
| 17930994 | SUBSTERNAL LEADLESS ELECTRICAL STIMULATION SYSTEM | September 2022 | July 2025 | Abandon | 34 | 2 | 0 | Yes | No |
| 17910209 | ENHANCING AUDITORY PERCEPTS WITH VESTIBULAR SIMULATION | September 2022 | August 2025 | Allow | 35 | 1 | 1 | No | No |
| 17894889 | WEARABLE SYSTEM FOR THE EAR | August 2022 | November 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17887160 | DETECTION OF ATRIAL FIBRILLATION | August 2022 | March 2025 | Allow | 31 | 3 | 0 | No | No |
| 17884903 | MOTOR CABLES FOR INTRAVASCULAR BLOOD PUMPS | August 2022 | May 2025 | Allow | 33 | 1 | 1 | No | No |
| 17759731 | Selective Stimulation of Peripheral Nerves | July 2022 | September 2025 | Allow | 38 | 1 | 1 | No | No |
| 17875310 | Implant Including Nanogenerator | July 2022 | April 2025 | Allow | 32 | 1 | 1 | Yes | No |
| 17869091 | SYSTEMS AND METHODS OF INTEGRATING AMBULATORY MEDICAL DEVICES | July 2022 | April 2024 | Allow | 21 | 1 | 0 | No | No |
| 17792454 | SYSTEM FOR PREDICTING ADVERSE EVENT IN PATIENT | July 2022 | March 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17862055 | Systems And Methods Of Detecting And Treating Obstructive Sleep Apnea | July 2022 | March 2026 | Allow | 44 | 4 | 0 | Yes | No |
| 17811871 | SEMICONDUCTOR ACUPUNCTURE DEVICE AND METHOD OF USE | July 2022 | February 2025 | Allow | 31 | 2 | 0 | Yes | No |
| 17840994 | METHOD OF PERCUTANEOUSLY IMPLANTING A MEDICAL IMPLANT AND A DELIVERY DEVICE FOR PERCUTANEOUS DELIVERY OF A MEDICAL IMPLANT | June 2022 | March 2025 | Allow | 33 | 1 | 1 | No | No |
| 17784278 | IMPLANTABLE GUIDE ELEMENT AND METHODS OF FABRICATION AND USE THEREOF | June 2022 | October 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17783497 | DEVICE FOR CLASSIFYING CONDITION OF SUBJECT AND NON-TRANSITORY COMPUTER-READABLE MEDIUM HAVING RECORDED COMPUTER PROGRAM FOR THE DEVICE | June 2022 | December 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17782694 | PROVIDING FEEDBACK ON A TREATMENT OPERATION PERFORMED ON A BODY PART OF A SUBJECT | June 2022 | September 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17782304 | RUNTIME OPTIMISED ARTIFICIAL VISION | June 2022 | August 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17743436 | CARDIAC EVENT SENSING IN AN IMPLANTABLE MEDICAL DEVICE | May 2022 | October 2024 | Allow | 29 | 1 | 0 | No | No |
| 17738544 | DISTRIBUTED DEVICE CONTROL AND WEARABLE SYSTEM FOR VAGUS NERVE STIMULATION | May 2022 | February 2026 | Allow | 46 | 2 | 1 | No | No |
| 17736432 | CARTILAGE TREATMENT | May 2022 | March 2026 | Allow | 46 | 2 | 0 | No | No |
| 17661150 | SUBSTERNAL ELECTRICAL STIMULATION SYSTEM | April 2022 | January 2026 | Allow | 45 | 4 | 0 | Yes | No |
| 17731801 | VESTIBULAR NERVE STIMULATION | April 2022 | June 2024 | Allow | 26 | 1 | 1 | No | No |
| 17661103 | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) SYSTEM INCLUDING SUBSTERNAL LEAD | April 2022 | July 2025 | Allow | 39 | 3 | 0 | Yes | No |
| 17661078 | PULSE APPLICATION METHOD AND PULSE APPLICATION DEVICE | April 2022 | April 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17724821 | METHOD FOR NEUROMODULATION TREATMENT OF NEURODEGENERATIVE DISEASE | April 2022 | January 2023 | Allow | 9 | 1 | 0 | No | No |
| 17659966 | Stimulation Modes to Adapt Customized Stimulation Parameters for Use in a Spinal Cord Stimulation System | April 2022 | February 2024 | Allow | 22 | 1 | 0 | No | No |
| 17657820 | ELECTROCARDIOGRAM DEVICE AND DOCKING STATIONS | April 2022 | August 2025 | Allow | 40 | 3 | 0 | Yes | No |
| 17707674 | COLLECTION OF CLINICAL DATA FOR GRAPHICAL REPRESENTATION AND ANALYSIS | March 2022 | February 2024 | Allow | 22 | 1 | 0 | No | No |
| 17691694 | CONFIGURABLE COMPARATOR ECG STORAGE AND DISPLAY IN A WEARABLE DEFIBRILLATOR SYSTEM | March 2022 | June 2025 | Allow | 40 | 2 | 0 | No | No |
| 17651735 | SYSTEMS AND METHODS FOR DETECTING MENTAL FATIGUE BY A USER OF AN IHS (INFORMATION HANDLING SYSTEM) | February 2022 | February 2025 | Allow | 36 | 1 | 0 | No | No |
| 17650459 | COMPRESSIBLE, MINIMALLY INVASIVE IMPLANTS AND RELATED SYSTEMS AND METHODS | February 2022 | October 2025 | Allow | 44 | 1 | 1 | Yes | No |
| 17565327 | SURGICAL SYSTEM AND PROCEDURE FOR TREATMENT OF THE TRABECULAR MESHWORK AND SCHLEMM'S CANAL USING A FEMTOSECOND LASER | December 2021 | February 2024 | Allow | 26 | 3 | 0 | Yes | No |
| 17561437 | NEUROMODULATION MEDICAL TREATMENT DEVICE | December 2021 | August 2023 | Allow | 19 | 2 | 1 | No | No |
| 17644765 | APPARATUS AND METHODS FOR MAINTAINING PHYSIOLOGICAL FUNCTIONS | December 2021 | December 2024 | Allow | 36 | 2 | 0 | No | No |
| 17552311 | INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE AND MANUFACTURE | December 2021 | December 2023 | Allow | 24 | 1 | 0 | No | No |
| 17643851 | ABLATION SYSTEMS AND METHODS FOR TREATING PRESBYOPIA | December 2021 | March 2025 | Allow | 39 | 3 | 0 | Yes | No |
| 17545739 | IMPLANTABLE ELECTRODE DEVICE AND METHOD OF FORMING AN IMPLANTABLE ELECTRODE DEVICE | December 2021 | January 2025 | Allow | 37 | 1 | 1 | No | No |
| 17596340 | Spinal Cord Stimulation System Determining Optimal Sub-Perception Therapy by Using Neural Dose | December 2021 | June 2025 | Allow | 42 | 1 | 1 | No | No |
| 17542940 | BLOOD PUMP | December 2021 | July 2023 | Allow | 19 | 0 | 0 | No | No |
| 17541554 | COMPUTER-ASSISTED TELE-OPERATED SURGERY SYSTEMS AND METHODS | December 2021 | August 2024 | Allow | 32 | 2 | 0 | No | No |
| 17539235 | METHOD AND SYSTEM FOR VALIDATING SAFETY OF A MEDICAL DEVICE WHEN EXPOSED TO MAGNETIC RESONANCE IMAGING FIELDS | December 2021 | February 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17613869 | SYSTEMS AND METHODS FOR TREATING INCONTINENCE | November 2021 | March 2025 | Allow | 39 | 2 | 0 | No | No |
| 17455585 | DEVICES, SYSTEMS, AND METHODS FOR TREATING AND PREVENTING DISEASE | November 2021 | August 2025 | Allow | 45 | 2 | 1 | Yes | No |
| 17527341 | ELECTRODE CONNECTION AND METHOD THEREFOR | November 2021 | July 2023 | Allow | 20 | 0 | 0 | No | No |
| 17595169 | METHODS TO REDUCE FLASHES ON ELECTRODES | November 2021 | January 2025 | Allow | 38 | 1 | 1 | No | No |
| 17609756 | A TISSUE STIMULATION DEVICE WITH DISTAL AND PROXIMAL RETURN ELECTRODE | November 2021 | April 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17453611 | LOW HEALTHCARE PROVIDER INTERACTION AND OUTCOME BASED PROGRAMMING | November 2021 | December 2024 | Allow | 37 | 0 | 1 | No | No |
| 17607062 | FLEXIBLE ELECTRODE MADE OF A METAL BASE MATERIAL | October 2021 | June 2024 | Allow | 32 | 0 | 0 | No | No |
| 17510019 | ELASTIC NEURAL ELECTRODE AND METHOD FOR FABRICATING THE SAME | October 2021 | January 2022 | Allow | 3 | 0 | 0 | No | No |
| 17451255 | ELECTROCARDIOGRAM PROCESSING SYSTEM FOR DELINEATION AND CLASSIFICATION | October 2021 | April 2022 | Allow | 6 | 2 | 0 | Yes | No |
| 15734523 | SYSTEMS AND METHODS FOR DETERMINING A FLOW SPEED OF A FLUID FLOWING THROUGH A CARDIAC ASSIST DEVICE | October 2021 | January 2025 | Allow | 50 | 1 | 1 | No | No |
| 17498610 | MODULAR TREATMENT DEVICE | October 2021 | September 2023 | Allow | 23 | 0 | 0 | No | No |
| 17600649 | DEVICE FOR ACTING ON AT LEAST PARTS OF A BODY | October 2021 | July 2025 | Allow | 45 | 2 | 0 | No | No |
| 17492130 | Method and Apparatus for Accurate Placement of Electrocardiogram Electrodes | October 2021 | February 2025 | Allow | 41 | 3 | 0 | Yes | No |
| 17485292 | MINIMALLY INVASIVE LEADLESS NEUROSTIMULATION DEVICE | September 2021 | June 2023 | Allow | 21 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOCKELMAN, MARK.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner BOCKELMAN, MARK works in Art Unit 3792 and has examined 477 patent applications in our dataset. With an allowance rate of 87.2%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.
Examiner BOCKELMAN, MARK's allowance rate of 87.2% places them in the 66% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by BOCKELMAN, MARK receive 1.61 office actions before reaching final disposition. This places the examiner in the 31% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by BOCKELMAN, MARK is 31 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +8.4% benefit to allowance rate for applications examined by BOCKELMAN, MARK. This interview benefit is in the 39% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 35.6% of applications are subsequently allowed. This success rate is in the 80% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 45.1% of cases where such amendments are filed. This entry rate is in the 69% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 75.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 61% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 87.5% of appeals filed. This is in the 81% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 36.6% are granted (fully or in part). This grant rate is in the 25% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 3.6% of allowed cases (in the 81% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.8% of allowed cases (in the 77% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.